The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 83 | 4.9x | 20.1x | Above average | |
Growth | 28 | -5.6% | 5.6% | Below average | |
Quality | 34 | -147.3% | 7.6% | Below average | |
Safety | 37 | 2.2x | 0.4x | Near average | |
Capital Return | 67 | 1.86% | 2.19% | Above average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
biote Corp. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy biote Corp. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Biote Corp stock shows a state of complete stability in analyst estimates, as the projected target price settled at 3.25 dollars without any change during the past 7 and 30-day periods. This consistency reflects the absence of new catalysts or price revisions by the sole analyst covering the stock, indicating a steady technical outlook despite the price gap between the current price (1.99 dollars) and the target.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.